Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial-Reference-Cited by-同舟云学术

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

Published:2009-07 Issue:9685 Volume:374 Page:222-228
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

King Talmadge E,Albera Carlo,Bradford Williamson Z,Costabel Ulrich,Hormel Phil,Lancaster Lisa,Noble Paul W,Sahn Steven A,Szwarcberg Javier,Thomeer Michiel,Valeyre Dominique,du Bois Roland M

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement;Am J Respir Crit Care Med,2000

2. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias;Am J Respir Crit Care Med,2002

3. Determinants of survival in idiopathic pulmonary fibrosis;Schwartz;Am J Respir Crit Care Med,1994

4. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis;Bjoraker;Am J Respir Crit Care Med,1998

5. Predicting survival in idiopathic pulmonary fibrosis. Scoring system and survival model;King;Am J Respir Crit Care Med,2001

Cited by 454 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF);Expert Review of Clinical Pharmacology;2024-08-27

2. Idiopathic pulmonary fibrosis mortality: update on trends in the modern treatment era;European Respiratory Journal;2024-08

3. Integrating the assessment of quality of life in care and research in pulmonary fibrosis;Current Opinion in Pulmonary Medicine;2024-07-01

4. Immune mechanisms in fibrotic interstitial lung disease;Cell;2024-07

5. ATP-induced fibrogenic pathway in circulating cells obtained by idiopathic pulmonary fibrotic (IPF) patients is not blocked by nintedanib and pirfenidone;Biomedicine & Pharmacotherapy;2024-07